CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy, and Tomocube, a leader in holotomography (HT) technology, today announced a ...

A novel optical microscope utilizing diffraction tomography to generate 3D holographic images of unlabeled live cells is now available from Tomocube. Called HT-1, the new microscope delivers ...

Tomocube (Co-CEOs Yonggeun Park and Kihyun Hong), a specialized company in three-dimensional label-free cell imaging, announced on the 25th that it has finalized its public offering price at 16,000 ...

TomoCube, a South Korea-based developer of optical and microscopy platforms for bioimaging, expects its latest holotomography system to prove the value of the technique in a number of applications.

Tomocube is experiencing a sharp decline compared to its IPO price on the first day of listing on the KOSDAQ market. As of 10:29 AM on the 7th, Tomocube is trading at 11,700 KRW, down 26.88% from its ...

Tomocube, a global leader in 3D label-free imaging and analysis, proudly introduces the HT-X1™ Plus, a state-of-the-art bioimaging platform designed to meet the evolving needs of biomedical ...

The Korea Herald is publishing a series of articles highlighting South Korea’s promising start-ups in the emerging sectors of digital health care and next-generation medical devices. This is the third ...

Analyse the historical data and Tomocube Inc share price performance charts on this page. Our technical summary section provides analysis on Tomocube share price buy/sell indicators using real-time ...

-- First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection -- New system showcased at SPAOM24 (20th-22nd November ...